Canopy Growth to supply UK with four Canadian-grown medical cannabis strains

Canopy Growth Corporation, a leading Canadian producer of medical and recreational cannabis, has announced plans to supply four strains of Canadian-grown medical cannabis flower to the United Kingdom. The products will be commercialized by GROW Group U.K. Ltd. under Canopy Growth’s Spectrum Therapeutics brand, marking a key expansion into Europe’s medical cannabis market. The agreement follows the renewal of the European Union Good Manufacturing Practice certification at Canopy Growth’s Kincardine, Ontario cultivation facility, ensuring compliance with strict regulatory standards for medical cannabis production.